Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Commercial Sponsor
InxMed (Shanghai) Co., Ltd.
Scientific Title
A Phase Ib, Open-label Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activities of IN10018 as Monotherapy and Combination Therapy in Subjects With Metastatic Melanoma